Richard D. Scheyer

A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses

P. O’Connor, D. Li, M. S. Freedman et al. · Neurology · 2006 · 355 citations

Life Sciences, Neurology, Pharmacotherapy +16

Clinical and electrographic effects of acute anticonvulsant withdrawal in epileptic patients

David Marks, Amiram Katz, Richard D. Scheyer et al. · Neurology · 1991 · 57 citations

Medicine, Neurology, Pharmacotherapy +16

Phenytoin concentrations in the human brain: An in vivo microdialysis study

Richard D. Scheyer, M. J. During, Jane M. Hochholzer et al. · Epilepsy Research · 1994 · 56 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +14

Differentiation of Temporal Lobe Ictal Behavior Associated with Hippocampal Sclerosis and Tumors of Temporal Lobe

Susan S. Spencer, Richard D. Scheyer, Amiram Katz et al. · Epilepsia · 1994 · 54 citations

Medicine, Neurology, Neuroscience +14

Measurement of carbamazepine and carbamazepine epoxide in the human brain using in vivo microdialysis

Richard D. Scheyer, M. J. During, Dennis D. Spencer et al. · Neurology · 1994 · 46 citations

Medicine, Neuroscience, Pharmacology +11